logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Opioidinduced Constipation

    FiltersReset Filters
    4 results

    • movantik

      (naloxegol oxalate)
      RedHill Biopharma Ltd
      Usage: MOVANTIK® is indicated for treating opioid-induced constipation (OIC) in adults with chronic non-cancer pain, including those with pain related to prior cancer or its treatment, who do not require frequent opioid dosage increases.

    • movantik

      (naloxegol oxalate)
      Valinor Pharma, LLC
      Usage: MOVANTIK® is indicated for treating opioid-induced constipation (OIC) in adults with chronic non-cancer pain, including those with chronic pain from prior cancer or its treatment, provided they do not require frequent opioid dosage escalation.

    • relistor

      (Methylnaltrexone bromide)
      Salix Pharmaceuticals, Inc.
      Usage: RELISTOR is indicated for treating opioid-induced constipation (OIC) in adults with chronic non-cancer pain or advanced illness requiring opioid escalation for palliative care, including those with chronic pain related to prior cancer or its treatment.

    • symproic

      (naldemedine)
      BioDelivery Sciences International Inc
      Usage: SYMPROIC is indicated for treating opioid-induced constipation (OIC) in adults with chronic non-cancer pain, including those with pain related to prior cancer or its treatment, who do not need frequent opioid dosage increases.